Janney Montgomery Scott LLC Lowers Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Janney Montgomery Scott LLC lessened its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 8.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,958 shares of the company’s stock after selling 4,624 shares during the period. Janney Montgomery Scott LLC’s holdings in Privia Health Group were worth $1,035,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of PRVA. Nordea Investment Management AB increased its position in shares of Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after buying an additional 86,910 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after acquiring an additional 143,446 shares in the last quarter. Franklin Resources Inc. increased its holdings in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after acquiring an additional 28,480 shares in the last quarter. Barclays PLC raised its position in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after acquiring an additional 158,188 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in Privia Health Group by 8.4% during the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after purchasing an additional 14,641 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Up 0.9 %

PRVA stock opened at $23.38 on Thursday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $23.62. The stock has a market cap of $2.81 billion, a price-to-earnings ratio of 233.82, a price-to-earnings-growth ratio of 3.09 and a beta of 0.87. The business has a fifty day moving average of $21.30 and a two-hundred day moving average of $20.05.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. Truist Financial increased their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. KeyCorp initiated coverage on Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective on the stock. Finally, Barclays upped their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $24.88.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.